A
4.55
-0.10 (-2.15%)
| Penutupan Terdahulu | 4.65 |
| Buka | 4.66 |
| Jumlah Dagangan | 587,085 |
| Purata Dagangan (3B) | 1,759,345 |
| Modal Pasaran | 120,588,144 |
| Harga / Buku (P/B) | 8.88 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Aug 2025 - 18 Aug 2025 |
| EPS Cair (TTM) | -2.24 |
| Nisbah Semasa (MRQ) | 10.68 |
| Aliran Tunai Operasi (OCF TTM) | -22.96 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -13.95 M |
| Pulangan Atas Aset (ROA TTM) | -91.05% |
| Pulangan Atas Ekuiti (ROE TTM) | -280.78% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Annovis Bio, Inc. | Menurun | Menurun |
AISkor Stockmoo
0.8
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | 1.5 |
| Volatiliti Harga | -3.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 0.80 |
|
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 14.69% |
| % Dimiliki oleh Institusi | 16.09% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Susquehanna International Group, Llp | 30 Sep 2025 | 218,421 |
| Merit Financial Group, Llc | 30 Sep 2025 | 81,316 |
| Greenwich Wealth Management Llc | 30 Sep 2025 | 47,400 |
| Wescott Financial Advisory Group, Llc | 30 Sep 2025 | 41,607 |
| Group One Trading Llc | 30 Sep 2025 | 34,627 |
| Lokken Investment Group Llc | 30 Sep 2025 | 29,248 |
| Xtx Topco Ltd | 30 Sep 2025 | 28,854 |
| Sterling Investment Advisors, Ltd. | 30 Sep 2025 | 23,416 |
| Julat 52 Minggu | ||
| Median | 17.00 (273.63%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Canaccord Genuity | 30 Sep 2025 | 17.00 (273.63%) | Beli | 2.07 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| HOFFMAN MICHAEL B | 4.09 | - | 39,200 | 160,328 |
| Jumlah Keseluruhan Kuantiti Bersih | 39,200 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 160,328 | |||
| Purata Pembelian Keseluruhan ($) | 4.09 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| HOFFMAN MICHAEL B | Pengarah | 24 Nov 2025 | Beli (+) | 39,200 | 4.09 | 160,328 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |